150 related articles for article (PubMed ID: 22759266)
1. Propionibacterium acnes host cell tropism contributes to vimentin-mediated invasion and induction of inflammation.
Mak TN; Fischer N; Laube B; Brinkmann V; Metruccio MM; Sfanos KS; Mollenkopf HJ; Meyer TF; Brüggemann H
Cell Microbiol; 2012 Nov; 14(11):1720-33. PubMed ID: 22759266
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells.
Fassi Fehri L; Mak TN; Laube B; Brinkmann V; Ogilvie LA; Mollenkopf H; Lein M; Schmidt T; Meyer TF; Brüggemann H
Int J Med Microbiol; 2011 Jan; 301(1):69-78. PubMed ID: 20943438
[TBL] [Abstract][Full Text] [Related]
3. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
4. Induction of toll-like receptors by Propionibacterium acnes.
Jugeau S; Tenaud I; Knol AC; Jarrousse V; Quereux G; Khammari A; Dreno B
Br J Dermatol; 2005 Dec; 153(6):1105-13. PubMed ID: 16307644
[TBL] [Abstract][Full Text] [Related]
5. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro.
Akaza N; Akamatsu H; Kishi M; Mizutani H; Ishii I; Nakata S; Matsunaga K
J Dermatol; 2009 Apr; 36(4):213-23. PubMed ID: 19348660
[TBL] [Abstract][Full Text] [Related]
6. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
Dessinioti C; Katsambas AD
Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
[TBL] [Abstract][Full Text] [Related]
7. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
[TBL] [Abstract][Full Text] [Related]
8. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
Lomholt HB; Kilian M
Ugeskr Laeger; 2008 Apr; 170(15):1234-7. PubMed ID: 18433578
[TBL] [Abstract][Full Text] [Related]
9. Propionibacterium acnes inhibits FOXM1 and induces cell cycle alterations in human primary prostate cells.
Sayanjali B; Christensen GJM; Al-Zeer MA; Mollenkopf HJ; Meyer TF; Brüggemann H
Int J Med Microbiol; 2016 Nov; 306(7):517-528. PubMed ID: 27424770
[TBL] [Abstract][Full Text] [Related]
10. Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution?
Cohen RJ; Shannon BA; McNeal JE; Shannon T; Garrett KL
J Urol; 2005 Jun; 173(6):1969-74. PubMed ID: 15879794
[TBL] [Abstract][Full Text] [Related]
11. Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes.
Jarrousse V; Castex-Rizzi N; Khammari A; Charveron M; Dréno B
Arch Dermatol Res; 2007 Nov; 299(9):441-7. PubMed ID: 17684752
[TBL] [Abstract][Full Text] [Related]
12. The evolving role of Propionibacterium acnes in acne.
Leyden JJ
Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
[TBL] [Abstract][Full Text] [Related]
13. Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity.
Jasson F; Nagy I; Knol AC; Zuliani T; Khammari A; Dréno B
Exp Dermatol; 2013 Sep; 22(9):587-92. PubMed ID: 23947673
[TBL] [Abstract][Full Text] [Related]
14. Does inflammatory acne result from imbalance in the keratinocyte innate immune response?
Grange PA; Weill B; Dupin N; Batteux F
Microbes Infect; 2010 Dec; 12(14-15):1085-90. PubMed ID: 20691803
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
16. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
[TBL] [Abstract][Full Text] [Related]
17. Acne vaccines targeting Propionibacterium acnes.
Kao M; Huang CM
G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
19. Acne: a new model of immune-mediated chronic inflammatory skin disease.
Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
[TBL] [Abstract][Full Text] [Related]
20. Evidence for diversity within Propionibacterium acnes: a comparison of the T-cell stimulatory activity of isolates from inflammatory acne, endocarditis and the laboratory.
Jappe U; Boit R; Farrar MD; Ingham E; Sandoe J; Holland KT
J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):450-4. PubMed ID: 15196160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
